A comparison of biological effects of three angiotensin Ii antagonists in sodium depleted hypertensive patients
Ogihara, T.; Nakamaru, M.; Higaki, J.; Hata, T.; Kumagai, A.; Kumahara, Y.
Medical Journal of Osaka University 34(1-2): 21-25
1983
ISSN/ISBN: 0030-6169 PMID: 6366501 Document Number: 210365
Document emailed within 1 workday
Related Documents
Denolle, T.; Luo, P.; Guyene, T.T.; Cazaubon, C.; Sissmann, J.; Corvol, P.; Ménard, J. 1993: Acute effects of a pseudo-tetrapeptide as renin inhibitor on blood pressure and renin-angiotensin system of sodium-repleted and sodium-depleted hypertensive patients Arzneimittel-Forschung 43(2a): 255-259Humke, U.; Levens, N.; Wood, J.; Hofbauer, K. 1992: The acute renal actions of angiotensin converting enzyme inhibitors in the sodium-depleted conscious primate are mediated by inhibition of the renin-angiotensin system Journal of Pharmacology and Experimental Therapeutics 260(1): 29-35
Lau, K.; Thomas, D.; Salvi, D.; Martin, C.; Tan, S. 1986: Effects of high-calcium and/or high-sodium diet on basal and angiotensin II-stimulated blood pressure in the spontaneously hypertensive rat Journal of Hypertension. Supplement: Official Journal of the International Society of Hypertension 4(5): S126-S128
Jover, B.; Mimran, A. 1994: Angiotensin II receptor antagonists versus angiotensin converting enzyme inhibitors: effects on renal function Journal of Hypertension. Supplement: Official Journal of the International Society of Hypertension 12(9): S3-S9
Dang, A.-m.; Liu, G.-z.; Zhang, Y.-h.; Chen, G.-l. 2006: The effects of angiotensin Ii receptor blockers in hypertensive patients complicating hyperuricaemia Zhonghua Xin Xue Guan Bing Za Zhi 34(10): 882-885
Marchi, S.D.; Prior, M.; Zannoni, M.; Lucchese, L.; Arosio, E. 1999: Effects of an angiotensin Ii receptor antagonist (valsartan) on macro- and microcirculatory hemodynamics of the arm in hypertensive patients Minerva Cardioangiologica 47(12): 554-556
Nitenberg, A.; Antony, I. 1998: Acute effects of angiotensin-converting enzyme inhibition on coronary vasomotion in hypertensive patients European Heart Journal 19(Suppl): J45-J51
Lijnen, P.J.; Fagard, R.H.; Amery, A.K. 1979: Effects of angiotensin Ii and 1-Sar-8-Ala-angiotensin Ii on the renal function in sodium-replete and -deplete dogs Archives Internationales de Physiologie et de Biochimie 87(1): 193-194
Zhou, H.; Bian, Y-fei.; Li, M-lian.; Gao, F.; Xiao, C-shi. 2010: Effects of RNA interference targeting angiotensin 1 receptor and angiotensin-converting enzyme on blood pressure and myocardial remodeling in spontaneous hypertensive rats Zhonghua Xin Xue Guan Bing Za Zhi 38(1): 60-66
Delgado, F.; Pastor, J.; García-Navío, J.L.; Vaquero, J.J.; Alvarez-Builla, J.; Sunkel, C.; de Casa-Juana, M.F.; Priego, J.G.; Santos, L.R.; Statkow, P.R.; Straumann, D. 1997: Nonpeptide angiotensin Ii receptor antagonists: synthesis and biological activity of 1H-imidazo and 1H-[1,2,3]-triazolo fused derivatives Farmaco 52(3): 147-155
Vásová, I.; Mayer, J. 1995: Biological effects of allogenic leukocytes and leukocyte-depleted blood cell products Vnitrni Lekarstvi 41(10): 713-718
Benetos, A.; Gautier, S.; Ricard, S.; Topouchian, J.; Asmar, R.; Poirier, O.; Larosa, E.; Guize, L.; Safar, M.; Soubrier, F.; Cambien, F. 1996: Influence of angiotensin-converting enzyme and angiotensin II type 1 receptor gene polymorphisms on aortic stiffness in normotensive and hypertensive patients Circulation 94(4): 698-703
Ogihara, T.; Maruyama, A.; Mikami, H.; Naka, T.; Higaki, J.; Kanda, T.; Gotoh, M.; Hata, T.; Kumahara, Y. 1979: Effects of a single dose of captopril on blood pressure and the renin-angiotensin-aldosterone system in normal subjects and hypertensive patients with various etiologies Nihon Jinzo Gakkai Shi 21(11): 1185-1192
Moore, G.J.; Taub, K.J. 1980: Effects of octapeptide and heptapeptide angiotensin antagonists in the rat and dog Proceedings of the Western Pharmacology Society 23: 339-343
Krekels, M.M.; Houben, A.J.; Lavrijssen, A.T.; van Es, P.N.; De Leeuw, P.W. 1996: Heterogeneous patterns of sodium excretion during sodium restriction in essential hypertensive patients Journal of Human Hypertension 10(Suppl 3): S123-S126
Dimitrov, Y.; Muller, S.; Hannedouche, T. 1997: Renal effects of AT1 angiotensin receptor antagonists (AT1ra) Presse Medicale 26(40): 1981-1986
Higashiura, K.; Shimamoto, K. 1999: The effects of angiotensin Ii receptor antagonists on insulin resistance Nihon Rinsho. Japanese Journal of Clinical Medicine 57(5): 1182-1186
Salgado, H.C.; Salgado, M.C.; Krieger, E.M. 1985: Hemodynamics and sodium balance in conscious sodium-depleted rats Brazilian Journal of Medical and Biological Research 18(1): 47-54
Somova, L.; Vassilev, T.; Bojkov, B.; Kirov, C.; Todorova, L. 1986: Humoral factors involved in the regulation of sodium-fluid balance in man. III. Renal prostaglandins and renin-angiotensin-aldosterone system in hypertensive disorders Acta Physiologica et Pharmacologica Bulgarica 12(4): 47-52
Ovchinnikov, A.G.; Serbul, V.M.; Ageev, F.T. 2009: Effects of renin-angiotensin system blockers on left ventricular hypertrophy and biochemical markers of collagen balance in patients with hypertensive hypertrophy Terapevticheskii Arkhiv 81(5): 64-71